Narrative Review Explores GLP-1 Agonists' Unclear Role in Bone Health and Orthopedic Surgery.
Background
GLP-1 receptor agonists are widely used for type 2 diabetes and obesity, also reducing cardiovascular events. Despite their increasing use, the specific effects of these agents on bone health and their implications for orthopedic surgery remain less understood. Patients with these conditions often face higher risks of fractures and surgical complications. Clarifying the interplay between GLP-1 agonists and bone metabolism is crucial for optimizing patient care, addressing a significant knowledge gap.
Study Design
This narrative review aimed to synthesize existing literature concerning GLP-1 receptor agonists and their effects on bone health and orthopedic surgery. Researchers conducted a comprehensive search of relevant databases to identify studies, focusing on preclinical and clinical data regarding bone mineral density, fracture risk, bone healing, and perioperative considerations. The methodology involved a qualitative synthesis of identified evidence, without performing a quantitative meta-analysis.
Key Findings
- GLP-1 agonists are widely used for type 2 diabetes and obesity, conditions common in orthopedic patients.
- The review explores potential mechanisms linking GLP-1 agonists to bone metabolism and surgical outcomes.
- Evidence specifically on GLP-1 agonist effects on orthopedic surgical outcomes and bone health is currently limited.
- A significant knowledge gap exists, necessitating more targeted research in this area.
Why It Matters
This narrative review highlights the critical need for further research into the effects of GLP-1 agonists on bone health and orthopedic surgery outcomes. Clinicians should be aware of the limited current evidence regarding perioperative management for GLP-1 agonist users. For peptide users and biohackers, this underscores an important area of ongoing investigation regarding systemic effects beyond metabolic control. Understanding these implications is vital for developing informed guidelines and optimizing care for a growing patient population on these medications.
glp-1 agonists
orthopedic surgery
bone health
type 2 diabetes
obesity
narrative review